Arkansas Children's Nutrition Center, Little Rock, AR, USA.
Arkansas Children's Research Institute, Little Rock, AR, USA.
J Nutr. 2020 Jul 1;150(7):1757-1764. doi: 10.1093/jn/nxaa096.
Branched-chain amino acid (BCAA) concentrations in the blood have been correlated with insulin resistance, but this relation throughout gestation (period in which insulin resistance typically increases) is unclear.
The objective of this study was to determine the associations between changes in BCAA concentrations and estimates of insulin resistance throughout gestation.
Serum BCAA (Leu, Ile, Val) concentrations and insulin resistance/sensitivity [i.e., homeostatic model assessment-2 of insulin resistance (HOMA2-IR), estimated metabolic clearance rate (MCR) of glucose, and estimated first- and second-phase insulin responses] were assessed at early (EP; 8.5 ± 0.2 wk) and/or late (LP; 29.2 ± 0.8 wk) pregnancy in 53 healthy women from the Glowing cohort. Adjusted Spearman correlations were used to evaluate the association between BCAA and insulin resistance/sensitivity measures at EP and LP, adjusted for body fat percentage and gestational weight gain (GWG). A multiple linear regression analysis was used to assess the association between changes in HOMA2-IR and BCAAs throughout gestation. Groups were made post hoc based on the mean percentage change (10% decrease) in Leu throughout gestation, creating a group with a ≥10% decrease in LeuLP-EP (BELOW) and a <10% decrease in LeuLP-EP (ABOVE), and Student's t tests were performed to assess differences between groups.
Leu and Ile concentrations positively correlated with HOMA2-IR at both time points, but these relations at EP disappeared/weakened when adjusted for body fat percentage. From EP to LP, the change in Leu (LeuLP-EP) was negatively associated with the change in HOMA2-IR (HOMA2-IRLP-EP) (β = -0.037, P = 0.006). MCR was lower in the BELOW group compared with the ABOVE group, whereas there was no difference in HOMA2-IR between groups.
In this pregnancy cohort, BCAA concentrations decreased throughout gestation, whereas the mean insulin resistance did not change. These data do not support a connection between changes in blood BCAA concentrations and estimates of insulin resistance in pregnant women. This trial is registered at clinicaltrials.gov as NCT01131117.
血液中支链氨基酸(BCAA)的浓度与胰岛素抵抗相关,但整个孕期(胰岛素抵抗通常增加的时期)中这种关系尚不清楚。
本研究旨在确定整个孕期中 BCAA 浓度变化与胰岛素抵抗评估指标之间的关联。
在 Glowing 队列中,53 名健康孕妇在早孕期(EP;8.5±0.2 周)和/或晚孕期(LP;29.2±0.8 周)分别检测血清 BCAA(亮氨酸、异亮氨酸、缬氨酸)浓度和胰岛素抵抗/敏感性[即,稳态模型评估-2 的胰岛素抵抗(HOMA2-IR)、葡萄糖估计代谢清除率(MCR)和估计的第一和第二相胰岛素反应]。调整 Spearman 相关系数以评估 EP 和 LP 时 BCAA 与胰岛素抵抗/敏感性指标之间的关联,调整了体脂百分比和妊娠体重增加(GWG)。使用多元线性回归分析评估整个孕期 HOMA2-IR 与 BCAA 变化之间的关联。根据整个孕期亮氨酸的平均百分比变化(减少 10%)进行事后分组,创建一个亮氨酸 LP-EP 减少≥10%的组(低于,BELOW)和亮氨酸 LP-EP 减少<10%的组(高于,ABOVE),并进行学生 t 检验以评估组间差异。
亮氨酸和异亮氨酸浓度在两个时间点均与 HOMA2-IR 呈正相关,但 EP 时这些关系在调整体脂百分比后消失/减弱。从 EP 到 LP,亮氨酸(LeuLP-EP)的变化与 HOMA2-IR(HOMA2-IRLP-EP)的变化呈负相关(β=-0.037,P=0.006)。BELOW 组的 MCR 低于 ABOVE 组,而两组之间的 HOMA2-IR 无差异。
在本妊娠队列中,BCAA 浓度在整个孕期下降,而平均胰岛素抵抗没有变化。这些数据不支持孕妇血液 BCAA 浓度变化与胰岛素抵抗评估指标之间存在关联。本试验在 clinicaltrials.gov 注册为 NCT01131117。